All three medications are approved by the FDA, but they have different doses and applications tailored to specific health conditions and populations.7 Other FDA approved GLP-1 receptor agonists for glycemic control include Dulaglutide SC (Trulicity), Exenatide injectable solution SC (Byetta), Exenatide injectable suspension SC, Liraglutide SC (Victoza), Liraglutide/insulin degludec (Xultophy), Lixisenatide/insulin glargine (Soliqua), and Tirzepatide (Mounjaro), which is also a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Frequently asked questions (FAQs) How are people getting Zepbound for free
Last week, the FDA accused Novo Nordisk of failing to develop proper procedures for reporting on side effects related to these popular diabetes and weight loss drugs
Where it does create pressure: Price anchoring
However, despite cultural messages to the contrary, weight loss does not automatically translate to increased body confidence and desire, Joy Berkheimer, PhD, LMFT, a sex and relationship therapist, tells SELF